David Dieter's most recent trade in Collegium Pharmaceutical Inc was a trade of 13,976 Common Stock done at an average price of $34.9 . Disclosure was reported to the exchange on March 18, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Collegium pharma Inc | David Dieter | EVP & General Counsel | Sale of securities on an exchange or to another person at price $ 34.92 per share. | 18 Mar 2026 | 13,976 | 77,071 (0%) | 0% | 34.9 | 488,099 | Common Stock |
| Collegium pharma Inc | David Dieter | EVP & General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 35.72 per share. | 17 Mar 2026 | 8,840 | 68,231 (0%) | 0% | 35.7 | 315,765 | Common Stock |
| Collegium pharma Inc | David Dieter | EVP & General Counsel | Sale of securities on an exchange or to another person at price $ 36.65 per share. | 09 Mar 2026 | 6,224 | 91,047 (0%) | 0% | 36.7 | 228,110 | Common Stock |
| Collegium pharma Inc | David Dieter | EVP & General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2026 | 22,194 | 91,047 (0%) | 0% | 0 | Common Stock | |
| Collegium pharma Inc | David Dieter | EVP & General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2026 | 9,005 | 100,052 (0%) | 0% | 0 | Common Stock | |
| Collegium pharma Inc | David Dieter | EVP & General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 46.75 per share. | 10 Feb 2026 | 2,781 | 97,271 (0%) | 0% | 46.8 | 130,012 | Common Stock |
| Collegium pharma Inc | David Dieter | EVP & General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2025 | 68,449 | 68,449 (0%) | 0% | 0 | Common Stock |